Inspire Investing LLC lessened its position in MaxLinear, Inc (NASDAQ:MXL – Free Report) by 14.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,304 shares of the semiconductor company’s stock after selling 4,484 shares during the quarter. Inspire Investing LLC’s holdings in MaxLinear were worth $388,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in MXL. Farther Finance Advisors LLC bought a new position in MaxLinear in the second quarter valued at $44,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of MaxLinear during the first quarter valued at about $49,000. Strs Ohio bought a new position in shares of MaxLinear during the first quarter valued at about $63,000. GAMMA Investing LLC grew its stake in shares of MaxLinear by 36.6% during the second quarter. GAMMA Investing LLC now owns 5,143 shares of the semiconductor company’s stock valued at $73,000 after buying an additional 1,378 shares during the last quarter. Finally, Larson Financial Group LLC grew its stake in shares of MaxLinear by 144.3% during the first quarter. Larson Financial Group LLC now owns 6,863 shares of the semiconductor company’s stock valued at $75,000 after buying an additional 4,054 shares during the last quarter. Institutional investors own 90.79% of the company’s stock.
MaxLinear Stock Up 3.1%
NASDAQ MXL opened at $17.40 on Thursday. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.55 and a quick ratio of 1.14. The stock has a market capitalization of $1.52 billion, a PE ratio of -7.04 and a beta of 1.77. MaxLinear, Inc has a 1 year low of $8.35 and a 1 year high of $25.73. The business’s 50-day moving average is $15.95 and its 200 day moving average is $13.76.
Insider Buying and Selling
In other MaxLinear news, insider Steven G. Litchfield sold 102,157 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $17.28, for a total value of $1,765,272.96. Following the completion of the sale, the insider directly owned 312,203 shares in the company, valued at $5,394,867.84. This trade represents a 24.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 7.80% of the stock is owned by company insiders.
Analyst Ratings Changes
MXL has been the topic of a number of recent research reports. Wall Street Zen raised MaxLinear from a “hold” rating to a “buy” rating in a research note on Saturday, September 20th. Zacks Research cut MaxLinear from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 22nd. Benchmark reaffirmed a “buy” rating and set a $25.00 price objective on shares of MaxLinear in a research note on Tuesday, September 2nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of MaxLinear in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company raised their price objective on MaxLinear from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Thursday, July 24th. Four research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, MaxLinear presently has an average rating of “Hold” and a consensus target price of $19.31.
Read Our Latest Analysis on MXL
MaxLinear Company Profile
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Read More
- Five stocks we like better than MaxLinear
- How Investors Can Find the Best Cheap Dividend Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is a Special Dividend?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- The Significance of Brokerage Rankings in Stock Selection
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding MXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MaxLinear, Inc (NASDAQ:MXL – Free Report).
Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.